Orthopediatrics Research Development vs Ebit Analysis

KIDS Stock

USD 26.34 0.13 0.49%

Orthopediatrics Corp financial indicator trend analysis is much more than just breaking down Orthopediatrics Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orthopediatrics Corp is a good investment. Please check the relationship between Orthopediatrics Corp Research Development and its Ebit accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

Research Development vs Ebit

Research Development vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orthopediatrics Corp Research Development account and Ebit. At this time, the significance of the direction appears to have pay attention.

The correlation between Orthopediatrics Corp's Research Development and Ebit is -0.77. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebit in the same time period over historical financial statements of Orthopediatrics Corp, assuming nothing else is changed. The correlation between historical values of Orthopediatrics Corp's Research Development and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Orthopediatrics Corp are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Research Development i.e., Orthopediatrics Corp's Research Development and Ebit go up and down completely randomly.

Correlation Coefficient

-0.77

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Research Development

Ebit

Most indicators from Orthopediatrics Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orthopediatrics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Discontinued Operations is likely to drop (988.5 K) in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	2.4M	198K	188.1K
Depreciation And Amortization	10.7M	13.1M	17.4M	18.3M

Interest Expense Depreciation And Amortization

Orthopediatrics Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.54	0.95	0.98	1.0	0.72	0.96	0.93	0.61	-0.53	-0.98	0.91	0.25	0.99	-0.54	0.85	0.97	0.89	0.91	0.52	0.97	1.0	1.0	0.8	0.96	0.95
Short Long Term Debt Total	-0.54		-0.66	-0.56	-0.53	-0.77	-0.3	-0.53	-0.64	-0.22	0.45	-0.44	0.55	-0.64	1.0	-0.34	-0.39	-0.42	-0.58	-0.29	-0.47	-0.56	-0.5	-0.5	-0.5	-0.42
Other Current Liab	0.95	-0.66		0.99	0.94	0.83	0.85	0.87	0.71	-0.38	-0.93	0.85	0.08	0.97	-0.66	0.7	0.92	0.8	0.85	0.53	0.94	0.95	0.93	0.81	0.92	0.87
Total Current Liabilities	0.98	-0.56	0.99		0.96	0.79	0.91	0.9	0.69	-0.5	-0.97	0.9	0.21	0.98	-0.56	0.78	0.95	0.85	0.87	0.57	0.95	0.97	0.96	0.84	0.93	0.93
Total Stockholder Equity	1.0	-0.53	0.94	0.96		0.67	0.96	0.92	0.55	-0.51	-0.96	0.89	0.23	0.98	-0.53	0.84	0.98	0.88	0.9	0.44	0.98	0.99	0.99	0.75	0.97	0.94
Other Liab	0.72	-0.77	0.83	0.79	0.67		0.53	0.69	0.96	-0.28	-0.74	0.71	-0.04	0.79	-0.77	0.55	0.6	0.66	0.73	0.8	0.62	0.74	0.69	0.89	0.61	0.68
Net Tangible Assets	0.96	-0.3	0.85	0.91	0.96	0.53		0.87	0.44	-0.68	-0.95	0.87	0.47	0.9	-0.3	0.88	0.97	0.88	0.84	0.43	0.94	0.94	0.97	0.7	0.92	0.93
Property Plant And Equipment Net	0.93	-0.53	0.87	0.9	0.92	0.69	0.87		0.62	-0.52	-0.91	0.96	0.26	0.92	-0.53	0.88	0.88	0.97	0.97	0.53	0.86	0.93	0.93	0.84	0.86	0.97
Current Deferred Revenue	0.61	-0.64	0.71	0.69	0.55	0.96	0.44	0.62		-0.39	-0.66	0.68	0.11	0.66	-0.64	0.55	0.48	0.63	0.66	0.89	0.47	0.62	0.58	0.91	0.44	0.62
Net Debt	-0.53	-0.22	-0.38	-0.5	-0.51	-0.28	-0.68	-0.52	-0.39		0.61	-0.57	-0.93	-0.43	-0.21	-0.73	-0.56	-0.67	-0.54	-0.59	-0.46	-0.51	-0.58	-0.6	-0.38	-0.61
Retained Earnings	-0.98	0.45	-0.93	-0.97	-0.96	-0.74	-0.95	-0.91	-0.66	0.61		-0.93	-0.35	-0.96	0.46	-0.85	-0.96	-0.91	-0.9	-0.61	-0.94	-0.97	-0.98	-0.85	-0.93	-0.97
Accounts Payable	0.91	-0.44	0.85	0.9	0.89	0.71	0.87	0.96	0.68	-0.57	-0.93		0.33	0.89	-0.45	0.9	0.85	0.95	0.91	0.61	0.82	0.9	0.9	0.89	0.81	0.98
Cash	0.25	0.55	0.08	0.21	0.23	-0.04	0.47	0.26	0.11	-0.93	-0.35	0.33		0.13	0.54	0.51	0.32	0.43	0.25	0.4	0.2	0.23	0.3	0.33	0.13	0.37
Non Current Assets Total	0.99	-0.64	0.97	0.98	0.98	0.79	0.9	0.92	0.66	-0.43	-0.96	0.89	0.13		-0.64	0.79	0.95	0.86	0.91	0.54	0.96	0.99	0.98	0.82	0.95	0.92
Long Term Debt	-0.54	1.0	-0.66	-0.56	-0.53	-0.77	-0.3	-0.53	-0.64	-0.21	0.46	-0.45	0.54	-0.64		-0.34	-0.39	-0.43	-0.59	-0.29	-0.47	-0.56	-0.51	-0.51	-0.5	-0.42
Cash And Short Term Investments	0.85	-0.34	0.7	0.78	0.84	0.55	0.88	0.88	0.55	-0.73	-0.85	0.9	0.51	0.79	-0.34		0.78	0.93	0.87	0.54	0.73	0.83	0.87	0.77	0.71	0.9
Net Receivables	0.97	-0.39	0.92	0.95	0.98	0.6	0.97	0.88	0.48	-0.56	-0.96	0.85	0.32	0.95	-0.39	0.78		0.84	0.86	0.43	0.99	0.97	0.98	0.72	0.97	0.92
Common Stock Total Equity	0.89	-0.42	0.8	0.85	0.88	0.66	0.88	0.97	0.63	-0.67	-0.91	0.95	0.43	0.86	-0.43	0.93	0.84		0.96	0.56	0.8	0.89	0.91	0.84	0.79	0.97
Common Stock Shares Outstanding	0.91	-0.58	0.85	0.87	0.9	0.73	0.84	0.97	0.66	-0.54	-0.9	0.91	0.25	0.91	-0.59	0.87	0.86	0.96		0.56	0.83	0.92	0.92	0.84	0.83	0.94
Non Current Liabilities Total	0.52	-0.29	0.53	0.57	0.44	0.8	0.43	0.53	0.89	-0.59	-0.61	0.61	0.4	0.54	-0.29	0.54	0.43	0.56	0.56		0.37	0.54	0.51	0.89	0.34	0.57
Inventory	0.97	-0.47	0.94	0.95	0.98	0.62	0.94	0.86	0.47	-0.46	-0.94	0.82	0.2	0.96	-0.47	0.73	0.99	0.8	0.83	0.37		0.96	0.96	0.68	0.99	0.89
Other Current Assets	1.0	-0.56	0.95	0.97	0.99	0.74	0.94	0.93	0.62	-0.51	-0.97	0.9	0.23	0.99	-0.56	0.83	0.97	0.89	0.92	0.54	0.96		0.99	0.81	0.96	0.94
Other Stockholder Equity	1.0	-0.5	0.93	0.96	0.99	0.69	0.97	0.93	0.58	-0.58	-0.98	0.9	0.3	0.98	-0.51	0.87	0.98	0.91	0.92	0.51	0.96	0.99		0.79	0.95	0.95
Total Liab	0.8	-0.5	0.81	0.84	0.75	0.89	0.7	0.84	0.91	-0.6	-0.85	0.89	0.33	0.82	-0.51	0.77	0.72	0.84	0.84	0.89	0.68	0.81	0.79		0.65	0.85
Property Plant And Equipment Gross	0.96	-0.5	0.92	0.93	0.97	0.61	0.92	0.86	0.44	-0.38	-0.93	0.81	0.13	0.95	-0.5	0.71	0.97	0.79	0.83	0.34	0.99	0.96	0.95	0.65		0.89
Short Long Term Debt	0.95	-0.42	0.87	0.93	0.94	0.68	0.93	0.97	0.62	-0.61	-0.97	0.98	0.37	0.92	-0.42	0.9	0.92	0.97	0.94	0.57	0.89	0.94	0.95	0.85	0.89

Click cells to compare fundamentals

Orthopediatrics Corp Account Relationship Matchups

Orthopediatrics Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	194.6M	320.4M	304.3M	427.7M	438.7M	460.7M
Short Long Term Debt Total	26.3M	1.5M	1.0M	907K	10.1M	10.4M
Other Current Liab	2.7M	24.9M	20.3M	19.6M	28.9M	30.3M
Total Current Liabilities	13.7M	35.0M	29.7M	30.9M	41.7M	43.7M
Total Stockholder Equity	142.4M	234.8M	225.4M	378.6M	377.0M	395.9M
Net Tangible Assets	109.6M	100.0M	83.3M	211.9M	243.7M	255.9M
Property Plant And Equipment Net	21.3M	27.2M	28.5M	34.3M	41.0M	21.9M
Current Deferred Revenue	4.3M	23.1M	18.2M	6.0M	6.8M	7.8M
Net Debt	(44.5M)	(27.3M)	(6.6M)	(8.1M)	(21.0M)	(22.0M)
Retained Earnings	(128.8M)	(161.8M)	(178.0M)	(176.8M)	(197.7M)	(207.6M)
Accounts Payable	6.5M	10.0M	9.3M	11.2M	12.6M	7.2M
Cash	70.8M	28.8M	7.6M	9.0M	31.1M	28.9M
Non Current Assets Total	66.5M	162.0M	170.6M	201.0M	212.2M	222.9M
Long Term Debt	26.1M	1.0M	907K	763K	9.9M	10.3M
Cash And Short Term Investments	70.8M	83.9M	53.5M	118.3M	80.3M	57.4M
Net Receivables	16.6M	17.5M	17.9M	24.8M	34.6M	36.3M
Common Stock Shares Outstanding	14.6M	18.1M	19.3M	20.9M	22.7M	14.9M
Liabilities And Stockholders Equity	194.6M	320.4M	304.3M	427.7M	438.7M	460.7M
Non Current Liabilities Total	38.5M	50.6M	49.2M	18.2M	20.1M	29.5M
Inventory	38M	53.0M	57.6M	78.2M	105.9M	111.1M
Other Current Assets	2.7M	4.0M	4.6M	5.4M	5.7M	6.0M
Other Stockholder Equity	271.2M	388.6M	394.9M	560.8M	580.3M	609.3M
Total Liab	52.2M	85.6M	78.9M	49.1M	61.7M	50.0M
Property Plant And Equipment Gross	21.3M	27.2M	51.6M	65.1M	80.6M	84.7M
Short Long Term Debt	124K	131K	137K	144K	152K	134.6K
Total Current Assets	128.1M	158.4M	133.6M	226.7M	226.5M	122.2M
Accumulated Other Comprehensive Income	(3K)	7.9M	8.5M	(5.4M)	(5.5M)	(5.2M)
Short Term Debt	124K	131K	137K	144K	152K	134.6K
Intangible Assets	19.0M	64.2M	69.8M	79.9M	84.6M	88.8M
Property Plant Equipment	21.3M	27.2M	28.5M	34.3M	39.4M	41.4M
Other Assets	1.6M	1.9M	2.2M	14.0K	12.6K	11.9K
Capital Surpluse	271.2M	388.6M	394.9M	560.8M	644.9M	677.2M
Non Currrent Assets Other	(54.1M)	8.2M	9.5M	(6.0M)	2.9M	3.1M
Retained Earnings Total Equity	(128.8M)	(161.8M)	(178.0M)	(176.8M)	(159.1M)	(167.0M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Orthopediatrics Stock Analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC